CIK 0001840706 · Accelerated filer<br>Emerging growth company
SOPHiA GENETICS SA
Sign in to watch- Ticker
- SOPH
- Exchange
- Nasdaq
- Industry
- Services-Computer Processing & Data Preparation
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- other
- Phone
- 41 21 694 10 60
- Business address
- LA PIECE, CH-1180, ROLLE, Switzerland, 00000
- Open-market buys, last 90 days
- $278,388
- in 2 filings
- Open-market sales, last 90 days
- $1,679,030
- in 28 filings, $1.6M under 10b5-1 plans
Net −$1,400,642. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 34 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-26 | Camblong Jurgi Chief Executive Officer | Sale 10b5-1 | −18,129 | $5.73 | $104K | 3,601,493 |
| 2026-06-26 | Camblong Jurgi Chief Executive Officer | Option exercise 10b5-1 | +31,940 | $3.16 | $101K | 3,633,433 |
| 2026-06-26 | Camblong Jurgi Chief Executive Officer | Sale 10b5-1 | −31,940 | $5.84 | $186K | 3,601,493 |
| 2026-06-26 | Camblong Jurgi Chief Executive Officer | Option exercise · Share Option (Right to Buy) 10b5-1 | −31,940 | 68,060 | ||
| 2026-06-25 | Camblong Jurgi Chief Executive Officer | Sale 10b5-1 | −1,373 | $5.70 | $8K | 3,619,622 |
| 2026-06-25 | Verma Abhimanyu Chief Technology Officer | Sale 10b5-1 | −6,944 | $5.51 | $38K | 197,456 |
| 2026-06-25 | Menu Philippe Chief Medical Officer | Sale 10b5-1 | −5,000 | $5.50 | $28K | 240,780 |
| 2026-06-22 | CARDOZA GEORGE Chief Financial Officer | Sale 10b5-1 | −774 | $5.38 | $4K | 310,684 |
| 2026-06-22 | Muken Ross President | Sale 10b5-1 | −422 | $5.38 | $2K | 680,489 |
| 2026-06-18 | Cox Troy Director | Grant or award | +19,724 | $5.46 | $108K | 328,743 |
| 2026-06-18 | Cox Troy Director | Grant or award · Share Option (Right to Buy) | +28,818 | $5.46 | $157K | 252,809 |
| 2026-06-18 | HIBBS KATHY L Director | Grant or award | +19,724 | $5.46 | $108K | 109,492 |
| 2026-06-18 | HIBBS KATHY L Director | Grant or award · Share Option (Right to Buy) | +28,818 | $5.46 | $157K | 218,569 |
| 2026-06-18 | Ossipow Vincent Director | Grant or award | +19,724 | $5.46 | $108K | 522,860 |
| 2026-06-18 | Ossipow Vincent Director | Grant or award · Share Option (Right to Buy) | +28,818 | $5.46 | $157K | 138,569 |
| 2026-06-18 | Cossery Jean-Michel Director | Grant or award | +19,724 | $5.46 | $108K | 206,212 |
| 2026-06-18 | Cossery Jean-Michel Director | Grant or award · Share Option (Right to Buy) | +28,818 | $5.46 | $157K | 138,449 |
| 2026-06-18 | HIRSCH DIDIER Director | Grant or award | +19,724 | $5.46 | $108K | 240,220 |
| 2026-06-18 | HIRSCH DIDIER Director | Grant or award · Share Option (Right to Buy) | +28,818 | $5.46 | $157K | 218,569 |
| 2026-06-15 | Xu Zhenyu Chief Scientific Officer | Sale 10b5-1 | −4,000 | $5.01 | $20K | 622,280 |
Page 5 of 8 · 157 trades